|
LOC100128191 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.86759999995812E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.517400E-03 |
| Normal-vs-Stage2 |
1.056400E-01 |
| Normal-vs-Stage3 |
1.118690E-03 |
| Normal-vs-Stage4 |
5.992100E-02 |
| Stage1-vs-Stage2 |
8.844400E-01 |
| Stage1-vs-Stage3 |
2.137600E-01 |
| Stage1-vs-Stage4 |
1.704590E-01 |
| Stage2-vs-Stage3 |
2.663000E-01 |
| Stage2-vs-Stage4 |
2.258800E-01 |
| Stage3-vs-Stage4 |
5.898400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69790999999808E-05 |
| Normal-vs-AfricanAmerican |
2.917900E-03 |
| Normal-vs-Asian |
3.052400E-01 |
| Caucasian-vs-AfricanAmerican |
2.902600E-01 |
| Caucasian-vs-Asian |
7.365600E-02 |
| AfricanAmerican-vs-Asian |
5.591600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24319999999611E-05 |
| Normal-vs-Female |
3.360100E-04 |
| Male-vs-Female |
9.577000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.460500E-03 |
| Normal-vs-Extreme_Weight |
4.081600E-03 |
| Normal-vs-Obese |
2.367800E-04 |
| Normal-vs-Extreme_Obese |
6.110400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.037800E-01 |
| Normal_Weight-vs-Obese |
4.043800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.822200E-01 |
| Extreme_Weight-vs-Obese |
7.638000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.386200E-01 |
| Obese-vs-Extreme_Obese |
2.326800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.083900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.58467999999967E-05 |
| Normal-vs-Age(61-80Yrs) |
1.102140E-03 |
| Normal-vs-Age(81-100Yrs) |
2.823600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.608400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.333600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.768760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.218800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.051400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.398000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.28450000003166E-06 |
| Normal-VS-Type2 PRCC |
1.029970E-01 |
| Normal-VS-KIRP CIMP |
5.395500E-02 |
| Normal-VS-Unclassified PRCC |
1.869740E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.163850E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.837800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.085600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.182800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.519800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.389800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.241300E-03 |
| Normal-vs-N1 |
1.581340E-03 |
| Normal-vs-N2 |
3.623600E-01 |
| N0-vs-N1 |
3.586200E-02 |
| N0-vs-N2 |
6.850600E-01 |
| N1-vs-N2 |
1.683870E-02 |
|
|
